🚀 ProPicks AI Hits +34.9% Return!Read Now

American Well COO Kurt Knight sells $28,836 in stock

Published 06/06/2024, 06:52 am
AMWL
-

American Well Corp (NYSE:AMWL) has reported a recent transaction by Chief Operating Officer Kurt Knight, who sold shares in the company. The transaction was executed on June 3, 2024, and involved the sale of 69,552 shares of Class A Common Stock at a price of $0.4146 per share, totaling approximately $28,836.

The sale was conducted to cover tax liabilities associated with the vesting and settlement of restricted stock units on June 1, 2024. According to the footnote in the SEC filing, these shares were sold through an automatic "sell to cover" transaction, which is a non-discretionary trade by the reporting person.

Following the transaction, Knight still holds a substantial stake in the company, with 3,005,777 shares of American Well Corp remaining in his possession. The company, known for its services in business services and headquartered in Boston, MA, continues its operations with Knight as a key executive member.

Investors and market watchers often monitor insider transactions such as these for insights into executive sentiment and company health. However, it's important to note that transactions like this one, which are executed to satisfy tax obligations, may not necessarily reflect changes in an executive's outlook on the company's future performance.

In other recent news, American Well Corp., also known as Amwell, has been the subject of several noteworthy developments. Piper Sandler, an investment firm, has maintained a neutral stance on the company, reflecting a cautious optimism towards Amwell's future. This follows a demonstration of Amwell's behavioral health solution at the Defense Health Agency (DHA), which showed potential for the company to secure high incremental gross margin software revenues.

Amwell's first-quarter earnings for 2024 revealed a 7% decline in total revenue year-over-year, amounting to $59.5 million. Despite the drop, the company has outlined a strong start to the year, with a focus on expanding its digital care enablement and the success of its Converge platform.

Looking ahead, Amwell projects a return to double-digit growth by 2025, with revenue expected to be between $335 million and $350 million. The company also anticipates an improved adjusted EBITDA and a rise in gross margins above 50% in the coming years.

These recent developments highlight Amwell's efforts to navigate the evolving digital health market, with strategic initiatives in place and a clear focus on expanding its digital care platform. The company remains confident in its future growth and profitability, as it continues to capitalize on opportunities presented by shifts in the healthcare solutions sector.

InvestingPro Insights

As American Well Corp (NYSE:AMWL) navigates through its financial journey, certain metrics and insights from InvestingPro shed light on its current standing. With a market capitalization of approximately $118.59 million, the company's size in the market is modest. The Price / Book ratio, which stands at 0.29 as of the last twelve months ending in Q1 2024, suggests that the stock may be undervalued relative to the company's assets, a point of interest for value investors.

Despite the recent insider transaction, AMWL's financial performance shows challenges, with a reported revenue decrease of 8.08% over the last twelve months as of Q1 2024. Additionally, the company's gross profit margin during the same period was 34.52%, which may be a silver lining for the company's ability to manage its cost of goods sold effectively. However, the company's operating income margin was -101.85%, reflecting significant operational losses.

InvestingPro Tips highlight that while AMWL holds more cash than debt on its balance sheet, it is quickly burning through cash and analysts do not anticipate the company will be profitable this year. Moreover, the stock has fared poorly, with a one-year price total return of -84.4% as of the latest available data, and is trading near its 52-week low. These insights suggest caution for investors considering the stock's recent performance and future outlook.

Investors looking to explore further into American Well Corp can find additional insights and tips on InvestingPro, with a total of 11 more tips available to help inform investment decisions. For those interested in gaining a deeper analysis, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.